NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal
4.6 (265) · $ 12.50 · In stock
An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
Vaccines platforms and COVID-19: what you need to know
Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect
Transcriptional correlates of malaria in RTS,S/AS01-vaccinated
Emerging concepts in the science of vaccine adjuvants
PDF) Vaccine Strategies to Elicit Mucosal Immunity
The Role of Vaccines in Combating Antimicrobial Resistance
Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and
Vaccines, Free Full-Text
Frontiers U-Omp19 from Brucella abortus Is a Useful Adjuvant for
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant
Frontiers Progress and Pitfalls in the Quest for Effective SARS
News - VaccineNation